Table 1.
Mean ± SD hourly heart rate (min−1) in 8 cats after oral administration of placebo and one dose of ivabradine (0.1 mg/kg, 0.3 mg/kg, and 0.5 mg/kg).
| Time (h) | Placebo | Ivabradine (mg/kg)
|
||
|---|---|---|---|---|
| 0.1 | 0.3 | 0.5 | ||
| Baseline | 147 ± 21 | 153 ± 8 | 154 ± 20 | 158 ± 12 |
| 1 | 156 ± 27 | 152 ± 24 | 149 ± 19a,b | 144 ± 23a,b |
| 2 | 146 ± 19 | 133 ± 16a | 119 ± 18a,b | 109 ± 15a,b |
| 3 | 144 ± 20 | 133 ± 22 | 112 ± 20a,b | 104 ± 11a,b,c |
| 4 | 157 ± 24 | 141 ± 19a | 120 ± 13a,b | 116 ± 14a,b,c |
| 5 | 167 ± 29 | 139 ± 18 | 128 ± 20 | 118 ± 14 |
| 6 | 156 ± 30 | 133 ± 20 | 128 ± 14 | 117 ± 11 |
| 7 | 157 ± 29 | 139 ± 18 | 131 ± 19 | 119 ± 15 |
| 8 | 157 ± 26 | 144 ± 16a | 127 ± 23a,b | 126 ± 19a,b |
| 9 | 148 ± 20 | 150 ± 28 | 135 ± 11 | 130 ± 26 |
| 10 | 146 ± 16 | 144 ± 22 | 124 ± 11 | 129 ± 22 |
| 11 | 146 ± 25 | 138 ± 15 | 125 ± 15 | 128 ± 19 |
| 12 | 141 ± 21 | 135 ± 16 | 128 ± 18a | 124 ± 16a,b |
| 13 | 143 ± 18 | 137 ± 17 | 126 ± 20 | 133 ± 17 |
| 14 | 145 ± 17 | 132 ± 14 | 132 ± 26 | 137 ± 21 |
| 15 | 143 ± 17 | 132 ± 16 | 133 ± 20 | 132 ± 20 |
| 16 | 149 ± 25 | 140 ± 22 | 135 ± 16 | 138 ± 20 |
| 17 | 149 ± 25 | 135 ± 12 | 136 ± 17 | 140 ± 21 |
| 18 | 142 ± 21 | 133 ± 15 | 138 ± 18 | 141 ± 27 |
| 19 | 139 ± 16 | 132 ± 14 | 144 ± 25 | 143 ± 25 |
| 20 | 141 ± 16 | 140 ± 25 | 134 ± 23 | 149 ± 25 |
| 21 | 141 ± 22 | 133 ± 11 | 131 ± 18 | 132 ± 15 |
| 22 | 142 ± 19 | 134 ± 11 | 141 ± 28 | 126 ± 17 |
Significant differences (P < 0.05) compared to placebo.
Significant differences (P < 0.05) compared to ivabradine (0.1 mg/kg).
Significant differences (P < 0.05) compared to ivabradine (0.3 mg/kg). Data were compared only at hours 0, 1, 2, 3, 4, 8, and 12.